Gritstone Bio Wins US Contract for COVID Vaccine Study

Gritstone bio on Wednesday secured a $433 million contract by the US government to conduct a mid-stage study of its self-amplifying mRNA COVID-19 vaccine candidate.
Reuters Health Information

source https://www.medscape.com/s/viewarticle/996878?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

Heart Failure Care Outside of ICU Can Lower Cost